تفاعل #1726711

ord-087b3c62b7454b1ba7e430bc3da69298

معادلة التفاعل

O=C1CCNCC1
4-piperidone
Cc1ccc(O)c(C(N)=O)c1
2-hydroxy-5-methylbenzamide
C1COCCN1
morpholine
Cc1ccc2c(c1)C(=O)NC1(CCNCC1)O2
Compound 137
Cc1ccc2c(c1)C(=O)NC1(CCNCC1)O2
6-methylspiro-[2H-1,3-benzoxazin-2,4′-piperidin]-4-(3H)-one

الكواشف

لا شيء

المذيبات

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    درجة الحرارةis refluxed for 20 hr
  2. 2
    غسيلwashed with water, brine
  3. 3
    تجفيفdried over Na2SO4
  4. 4
    أخرىAfter solvent removal by rotoevaporation
  5. 5
    أخرىthe crude product is purified by preparative TLC

الإجراء التجريبي

A mixture of 26 mg (0.083 mmol) of N-[4,8-dimethoxyquinoline-2-yl)carbonyl]-4-piperidone (prepared as described in Example 44), 12.5 mg (0.083 mmol) of 2-hydroxy-5-methylbenzamide, and 0.020 mL of morpholine in 2 mL of methanol is refluxed for 20 hr. The reaction mixture is diluted with ethyl acetate, and washed with water, brine, and dried over Na2SO4. After solvent removal by rotoevaporation, the crude product is purified by preparative TLC to give 20 mg (0.045 mmol, 54% yield) of 1′-[4,8-dimethoxyquinoline-2-yl)carbonyl]-6-methylspiro-[2H-1,3-benzoxazin-2,4′-piperidin]-4-(3H)-one (Compound 137): 1H NMR (DMSO-d6): δ 2.28 (s, 3H), 3.95 (s, 3H), 4.06 (s, 3H), 6.98 (d, 1H), 7.19 (s, 1H), 7.23 (d of d, 1H), 7.33 (d of d, 1H), 7.52 (d of d, 1H), 7.56 (d, 1H), 7.68 (d of d, 1H), and 8.77 ppm (s, 1H). MS m/z: 448.1 (M+H)+, 470.0 (M+Na)+.

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08110570B2uspto-grants-2012_02